Physician profile
Jesse Victor
NPI 1851738702
$1,053.64
in general payments reported to CMS, 2019-2025
7 companies · $49.96 in 2025
The $49.96 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.72 · 2021: $251 · 2022: $306 · 2023: $249 · 2024: $147 · 2025: $49.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $524.06 | 2020-2024 | Xarelto |
| Amgen INC. | $160.85 | 2022-2024 | Repatha |
| Pfizer INC. | $160.52 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $124.00 | 2021 | |
| Abbott Laboratories | $42.10 | 2023 | Jot Dx |
| Abbvie INC. | $21.82 | 2023 | Avycaz |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Victor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.